Cargando…

Targeting the DNA damage response for cancer therapy

The DNA damage response (DDR) is an elegant system, coordinating DNA repair with cell cycle checkpoints, that evolved to protect living organisms from the otherwise fatal levels of DNA damage inflicted by endogenous and environmental sources. Since many agents used to treat cancer; radiotherapy and...

Descripción completa

Detalles Bibliográficos
Autor principal:	Curtin, Nicola J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2023
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9988002/ https://www.ncbi.nlm.nih.gov/pubmed/36606678 http://dx.doi.org/10.1042/BST20220681

Ejemplares similares

Targeting the DNA Damage Response for Cancer Therapy
por: Wang, Ruoxi, et al.
Publicado: (2023)

Targeting DNA damage response in cancer therapy
por: Hosoya, Noriko, et al.
Publicado: (2014)

Targeting the DNA Damage Response for the Treatment of High Risk Neuroblastoma
por: Southgate, Harriet E. D., et al.
Publicado: (2020)

Determining the Potential of DNA Damage Response (DDR) Inhibitors in Cervical Cancer Therapy
por: Saha, Santu, et al.
Publicado: (2022)

Therapeutic Targeting of DNA Damage Response in Cancer
por: Choi, Wonyoung, et al.
Publicado: (2022)

Impact of DNA Damage Response—Targeted Therapies on the Immune Response to Tumours
por: Lutfi, Nura, et al.
Publicado: (2021)

Targeting DNA Damage Response and Immune Checkpoint for Anticancer Therapy
por: Huang, Jau-Ling, et al.
Publicado: (2022)

Targeting Oxidatively Induced DNA Damage Response in Cancer: Opportunities for Novel Cancer Therapies
por: Davalli, Pierpaola, et al.
Publicado: (2018)

Characterisation of Ovarian Cancer Cell Line NIH-OVCAR3 and Implications of Genomic, Transcriptomic, Proteomic and Functional DNA Damage Response Biomarkers for Therapeutic Targeting
por: Bradbury, Alice, et al.
Publicado: (2020)

Targeting DNA Damage Response in Prostate and Breast Cancer
por: Wengner, Antje M., et al.
Publicado: (2020)

Targeting the ATR-CHK1 Axis in Cancer Therapy
por: Rundle, Stuart, et al.
Publicado: (2017)

Harnessing the Nucleolar DNA Damage Response in Cancer Therapy
por: Xuan, Jiachen, et al.
Publicado: (2021)

DDRugging glioblastoma: understanding and targeting the DNA damage response to improve future therapies
por: Rominiyi, Ola, et al.
Publicado: (2021)

Targeting DNA Damage Response in the Radio(Chemo)therapy of Non-Small Cell Lung Cancer
por: Li, Ling, et al.
Publicado: (2016)

Targeting the DNA Damage Response Machinery for Lung Cancer Treatment
por: Venugopala, Katharigatta N.
Publicado: (2022)

Genomic, Transcriptomic, and Functional Alterations in DNA Damage Response Pathways as Putative Biomarkers of Chemotherapy Response in Ovarian Cancer
por: Sharma Saha, Sweta, et al.
Publicado: (2021)

DNA Damage Response in Cancer Therapy and Resistance: Challenges and Opportunities
por: Jurkovicova, Dana, et al.
Publicado: (2022)

Targeting the DNA Damage Response and DNA Repair Pathways to Enhance Radiosensitivity in Colorectal Cancer
por: Deng, Siyao, et al.
Publicado: (2022)

Targeting the DNA Damage Response to Overcome Cancer Drug Resistance in Glioblastoma
por: Ferri, Alessandra, et al.
Publicado: (2020)

Targeting the DNA damage response and repair in cancer through nucleotide metabolism
por: Helleday, Thomas, et al.
Publicado: (2022)

DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer
por: Huang, Rui-Xue, et al.
Publicado: (2020)

Roles of DNA damage repair and precise targeted therapy in renal cancer (Review)
por: Lai, Yongchang, et al.
Publicado: (2022)

Targeting the epigenetics of the DNA damage response in breast cancer
por: Montenegro, M F, et al.
Publicado: (2016)

Synthesis and Biological Evaluation of Cardiac Glycosides for Cancer Therapy by Targeting the DNA Damage Response
por: Ainembabazi, Diana, et al.
Publicado: (2022)

Targeting the DNA Damage Response for Cancer Therapy by Inhibiting the Kinase Wee1
por: Bukhari, Amirali B., et al.
Publicado: (2022)

Targeting the DNA Damage Response Pathway as a Novel Therapeutic Strategy in Colorectal Cancer
por: Catalano, Fabio, et al.
Publicado: (2022)

DNA damage response proteins in canine cancer as potential research targets in comparative oncology
por: Hernández‐Suárez, Beatriz, et al.
Publicado: (2022)

DNA Damage Response and Repair in Boron Neutron Capture Therapy
por: Mechetin, Grigory V., et al.
Publicado: (2023)

Strategies for targeting the DNA damage response for cancer therapeutics
por: Zhang, Dan, et al.
Publicado: (2012)

DNA repair in cancer: emerging targets for personalized therapy
por: Abbotts, Rachel, et al.
Publicado: (2014)

Targeting the Interplay between HDACs and DNA Damage Repair for Myeloma Therapy
por: Gkotzamanidou, Maria, et al.
Publicado: (2021)

DNA Damage Response Mechanisms in Head and Neck Cancer: Significant Implications for Therapy and Survival
por: Papalouka, Chara, et al.
Publicado: (2023)

H2AX Phosphorylation: Its Role in DNA Damage Response and Cancer Therapy
por: Podhorecka, Monika, et al.
Publicado: (2010)

Interplay between the DNA Damage Response and Immunotherapy Response in Cancer
por: Lee, Elizabeth Chun Yong, et al.
Publicado: (2022)

DNA damage repair: historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy
por: Huang, Ruixue, et al.
Publicado: (2021)

Targeting DNA Damage Response and Repair to Enhance Therapeutic Index in Cisplatin-Based Cancer Treatment
por: Kiss, Robert Csaba, et al.
Publicado: (2021)

Targeting DNA Damage Response and Replication Stress in Pancreatic Cancer
por: Dreyer, Stephan B., et al.
Publicado: (2021)

Sumoylation and the DNA Damage Response
por: Cremona, Catherine A., et al.
Publicado: (2012)

Autophagy in DNA Damage Response
por: Czarny, Piotr, et al.
Publicado: (2015)

Scorpins in the DNA Damage Response
por: Palmieri, Dario, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_bnv4cuqu41ofmgodt44n93qcp3